Health Professionals

#MedSafetyWeek

During the annual #MedSafetyWeek global campaign, the National Pharmaceutical Regulatory Agency (NPRA) collaborates with the Uppsala Monitoring Centre (UMC, the World Health Organisation Collaborating Centre for International Drug Monitoring), medicines regulatory authorities, and national pharmacovigilance centres around the world to raise awareness of medication safety and encourage reporting of suspected adverse drug reactions and adverse events following immunisation (ADR/AEFI).

Read more at who-umc.org/medsafetyweek.

Annual campaign

#MedSafetyWeek by year.

Every post from the annual global medication-safety campaign NPRA runs with the Uppsala Monitoring Centre.